These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 14977868

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
    Bournique B, Lambert N, Boukaiba R, Martinet M.
    Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The cytochrome P450-catalyzed metabolism of levomepromazine: a phenothiazine neuroleptic with a wide spectrum of clinical application.
    Wójcikowski J, Basińska A, Daniel WA.
    Biochem Pharmacol; 2014 Jul 15; 90(2):188-95. PubMed ID: 24841887
    [Abstract] [Full Text] [Related]

  • 27. Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4.
    Venkatakrishnan K, Greenblatt DJ, von Moltke LL, Schmider J, Harmatz JS, Shader RI.
    J Clin Pharmacol; 1998 Feb 15; 38(2):112-21. PubMed ID: 9549641
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9.
    Mancy A, Dijols S, Poli S, Guengerich P, Mansuy D.
    Biochemistry; 1996 Dec 17; 35(50):16205-12. PubMed ID: 8973193
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.
    Ha-Duong NT, Dijols S, Macherey AC, Goldstein JA, Dansette PM, Mansuy D.
    Biochemistry; 2001 Oct 09; 40(40):12112-22. PubMed ID: 11580286
    [Abstract] [Full Text] [Related]

  • 36. Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine.
    Olesen OV, Linnet K.
    Br J Clin Pharmacol; 2000 Dec 09; 50(6):563-71. PubMed ID: 11136295
    [Abstract] [Full Text] [Related]

  • 37. Stereoselective metabolism of rabeprazole-thioether to rabeprazole by human liver microsomes.
    Miura M, Satoh S, Tada H, Habuchi T, Suzuki T.
    Eur J Clin Pharmacol; 2006 Feb 09; 62(2):113-7. PubMed ID: 16389533
    [Abstract] [Full Text] [Related]

  • 38. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
    Wójcikowski J, Pichard-Garcia L, Maurel P, Daniel WA.
    Eur Neuropsychopharmacol; 2004 May 09; 14(3):199-208. PubMed ID: 15056479
    [Abstract] [Full Text] [Related]

  • 39. Effects of propofol on human hepatic microsomal cytochrome P450 activities.
    McKillop D, Wild MJ, Butters CJ, Simcock C.
    Xenobiotica; 1998 Sep 09; 28(9):845-53. PubMed ID: 9764927
    [Abstract] [Full Text] [Related]

  • 40. Identification of cytochrome P450 2C18 and 2C76 in tree shrews: P450 2C18 effectively oxidizes typical human P450 2C9/2C19 chiral substrates warfarin and omeprazole with less stereoselectivity.
    Uno Y, Minami Y, Tsukiyama-Kohara K, Murayama N, Yamazaki H.
    Biochem Pharmacol; 2024 Oct 09; 228():115990. PubMed ID: 38110158
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.